Nomax Inc

5 FDA enforcement actions

5 Total Recalls

0 Class I

4 Class II

1 Class III

Firm Details

Product Types: drug
States: MO

All Recalls

Class II: Risk 04/19/2024 drug

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class II: Risk 04/19/2024 drug

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class II: Risk 04/19/2024 drug

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class II: Risk 04/19/2024 drug

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class III: Low Risk 04/13/2021 drug

Subpotent Drug

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.